Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman‐Rossi, Augusto Villanueva, Jean‐Charles Nault, et al.
Gastroenterology (2015) Vol. 149, Iss. 5, pp. 1226-1239.e4
Open Access | Times Cited: 1163

Showing 1-25 of 1163 citing articles:

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle, Alejandro Forner, Josep M. Llovet, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 1, pp. 182-236
Closed Access | Times Cited: 10108
Hepatocellular carcinoma
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 4472
Hepatocellular Carcinoma
Augusto Villanueva
New England Journal of Medicine (2019) Vol. 380, Iss. 15, pp. 1450-1462
Closed Access | Times Cited: 3632
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally, Miruna Balasundaram, Rebecca Carlsen, et al.
Cell (2017) Vol. 169, Iss. 7, pp. 1327-1341.e23
Open Access | Times Cited: 2117
Hepatocellular carcinoma
Josep M. Llovet, Jessica Zucman‐Rossi, Eli Pikarsky, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 2110
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet, Robert Montal, Daniela Sia, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 10, pp. 599-616
Open Access | Times Cited: 1632
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix, María Reig, Morris Sherman
Gastroenterology (2016) Vol. 150, Iss. 4, pp. 835-853
Open Access | Times Cited: 1571
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik, Hashem B. El–Serag
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 477-491.e1
Open Access | Times Cited: 1502
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen, et al.
The Lancet Oncology (2019) Vol. 20, Iss. 2, pp. 282-296
Closed Access | Times Cited: 1436
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1272
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1147
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia, Augusto Villanueva, Scott L. Friedman, et al.
Gastroenterology (2016) Vol. 152, Iss. 4, pp. 745-761
Open Access | Times Cited: 1009
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Arndt Vogel, Andrés Cervantes, Ian Chau, et al.
Annals of Oncology (2018) Vol. 29, pp. iv238-iv255
Open Access | Times Cited: 882
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero, Jessica Zucman‐Rossi
Journal of Hepatology (2016) Vol. 64, Iss. 1, pp. S84-S101
Closed Access | Times Cited: 872
The immunology of hepatocellular carcinoma
Marc Ringelhan, Dominik Pfister, Tracy O’Connor, et al.
Nature Immunology (2018) Vol. 19, Iss. 3, pp. 222-232
Closed Access | Times Cited: 862
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia, Yang Jiao, Iris Martinez-Quetglas, et al.
Gastroenterology (2017) Vol. 153, Iss. 3, pp. 812-826
Open Access | Times Cited: 761
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 3, pp. 139-152
Closed Access | Times Cited: 681
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Caldéraro, Gabrielle Couchy, Sandrine Imbeaud, et al.
Journal of Hepatology (2017) Vol. 67, Iss. 4, pp. 727-738
Closed Access | Times Cited: 644
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Silvia Affò, Le–Xing Yu, Robert F. Schwabe
Annual Review of Pathology Mechanisms of Disease (2016) Vol. 12, Iss. 1, pp. 153-186
Open Access | Times Cited: 554
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
Nicole M. Kettner, Horatio Voicu, Milton J. Finegold, et al.
Cancer Cell (2016) Vol. 30, Iss. 6, pp. 909-924
Open Access | Times Cited: 454
Goals and targets for personalized therapy for HCC
Thomas Couri, Anjana Pillai
Hepatology International (2019) Vol. 13, Iss. 2, pp. 125-137
Closed Access | Times Cited: 452
Evolving therapeutic landscape of advanced hepatocellular carcinoma
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 442
Molecular and histological correlations in liver cancer
Julien Caldéraro, Marianne Ziol, Valérie Paradis, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 3, pp. 616-630
Open Access | Times Cited: 435
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
An Tang, Oussama Hallouch, Victoria Chernyak, et al.
Abdominal Radiology (2017) Vol. 43, Iss. 1, pp. 13-25
Closed Access | Times Cited: 427
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
Otília Menyhárt, Ádám Nagy, Balázs Győrffy
Royal Society Open Science (2018) Vol. 5, Iss. 12, pp. 181006-181006
Open Access | Times Cited: 426
Page 1 - Next Page

Scroll to top